A PYMNTS Company

US/Ireland: Pharmaceutical buyout nets $4.2B in rare disease treatment business

By  |  November 11, 2013

Ireland-based pharmaceutical company Shire has reportedly inked a deal to acquire U-based ViroPharma for $4.2 billion.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The buyout, reports say, will aid the Irish firm in expanding its business in rare disease treatments.

    The companies announced the deal Monday and said they expect to close the merger by the first quarter of 2014 pending regulatory approval.

    Full Content: Deal Book

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.